Read in Spanish
The National Assembly of Ecuador is about to vote for a reform that will decriminalize the therapeutic use of cannabis and enable national production.
This is one of the major reforms presented by the Organic Health Code (COS), a congress project in which at least 100 different types of projects were analyzed.
The project now awaits second debate in the National Assembly and if adopted, the Ministry of Public Health (MSP) will enable regulated access to cannabis through medical prescriptions.
The national production will be granted to cooperatives and to legal persons every five years, with the purpose of elaborating products based on cannabidiol (CBD), a medicinal compound supported by the World Health Organization (WHO).
The medical discussion has been led by Víctor Álvarez, president of the Pinchincha Medical College. For him, the code enables a new therapeutic option for the population through reliable distribution and production.
“There will be places where you can find the legally authorized medicinal cannabis, obviously under a medical prescription as it happens with tranquilizers sent by the doctor,” he said in a story published in the newspaper El Telégrano. .
It seems that the entry door of the regulation will be through CBD-only products. That is to say, that the requirements that arise for the concession, request to the products that the percentages do not exceed 1% of tetrahydrocannabinol (THC).
For the moment, specialists advocate this not so controversial compound, despite knowing that it limits the possibility of therapy of this type for the medicinal properties that also exist in THC, a psychoactive component whose low doses work very well in cancer patients. , fibromyalgia, chronic pain, Alzheimer’s and others.
Ecuador is concentrating for the moment on providing safe alternatives to the ailments. Gabrel Buitrón, representative of Ecuador Cannabico, attended the National Assembly where he explained that in the country there are more than 50,000 patients seeking this option. Mainly, children with epilepsies and patients with chronic pain.
The Uruguayan case continues to be taken as an example in world regulations. This was stated by Buitrón with respect to recent information released by the Uruguayan authorities regarding legalization.
“Uruguay received in 2018, $ 800 million for the sale of cannabis through the pharmacy. That money did not go to the drug traffic but to the coffers of the State. We must take responsibility for this social struggle that has been going on for a decade now. “
The National Assembly is expected to vote on the reform in the coming days.
Follow us on Instagram: @mcnglobal